Responses to parliamentary questions
Question from Deputy Pádraig Rice - PQ 74859-25
Deputy Rice asked if a decision not to reimburse Omaveloxolone (Skyclarys) will be reviewed. Read the HSE response.
From: Communications and public affairs
Published: January 2026
Updated: February 2026
Documents
Question from Deputy Pádraig Rice - PQ 74859-25
PDF, 651KB, 3 pages
Summary
To ask the Minister for Health if a decision not to reimburse a treatment will be reviewed (Omaveloxolone (sold under the brand name Skyclarys). It is the only pharmaceutical treatment available for treating Friedreich's Ataxia.); and if she will make a statement on the matter.
This is a beta version - your feedback will help us to improve it